Parkinson's Groups Push Congress to Double NIH Funding Amid $5B Cut Threat

Hook

Leading Parkinson's disease organizations—including the Michael J. Fox Foundation and the Parkinson's Foundation—have made an urgent appeal to Congress: increase annual NIH funding for Parkinson's research to $600 million. This request comes just as the FY2027 federal budget proposes slashing the NIH's overall funding by $5 billion, which, if enacted, could jeopardize ongoing and future Parkinson's and biomedical research. Read the advocacy statement here.

For researchers and organizations pursuing NIH grants—especially in neuroscience and neurodegenerative diseases—this collision of advocacy and austerity proposals could profoundly shape next year's funding landscape.

Context

NIH funding has long been considered the lifeblood of U.S. biomedical research, supporting tens of thousands of projects ranging from basic science to clinical trials. In 2023, the NIH operated with a $47.7 billion budget; the newly proposed federal budget not only halts the upward trajectory but calls for a $5 billion cut. For Parkinson's disease—the nation's second-most common neurodegenerative disorder—annual NIH funding stands at about $291 million, despite nearly 1 million Americans living with the illness.

Advocates point out that investment in NIH-backed Parkinson’s research has driven major scientific progress in diagnostics, therapeutics, and care models. Yet, compared to the societal and healthcare costs of Parkinson's (projected to reach $52 billion annually in the US this decade), current funding is widely regarded as insufficient. The call to double NIH’s investment to $600 million is presented as both necessary for accelerating breakthroughs and as a bulwark against potential cuts.

This urgency is amplified by the federal budget process, with powerful stakeholders—including patient advocacy groups, professional societies, and research institutions—often clashing with fiscal hawks and lawmakers seeking to tighten discretionary spending. The outcome of this year's "budget battle" will shape the research ecosystem for years.

Impact on Researchers, Nonprofits, and Small Businesses

For Researchers

If Congress adopts the proposed NIH cuts, paylines and success rates for grants—already highly competitive (e.g., less than 20% for R01 applications)—could drop even further. Parkinson’s-specific opportunities could shrink, raising the stakes for current applicants and potentially slowing the pipeline of innovations.

However, if Congress responds to advocacy by increasing (or even just preserving) current funding, research teams focusing on Parkinson’s, neuroscience, or related biomedical fields may see a renewed stream of RFAs (Requests for Applications) and greater flexibility in scope and duration of funded projects.

For Nonprofits and Advocacy Groups

Organizations that build programs or plan pilot studies based on federal grant availability face increased uncertainty. Aligning advocacy, coalition-building, and constituent engagement with Congressional timelines and appropriations cycles is now mission-critical. Nonprofits may also want to prepare stories and impact briefs showing how NIH-funded research drives real outcomes.

For Small Businesses (SBIR/STTR Applicants)

Small businesses innovating diagnostics, therapeutics, or digital health tools for Parkinson's should closely monitor how the budget discussion evolves. The availability of SBIR/STTR funding for neurodegenerative diseases could hinge on Congressional decisions. Firms should prepare alternative funding plans and strengthen collaborations with academic and nonprofit investigators.

Action Steps for Grant Seekers

1. Stay Informed: Track legislative developments via the NIH Office of Budget and major advocacy organizations.
2. Engage Policymakers: Consider joining coalition calls to action, such as sending letters to congressional representatives or participating in advocacy days.
3. Diversify Funding Strategies: Explore foundation, state, and industry grants as potential supplements.
4. Document Impact: Prepare evidence of how NIH funding is supporting critical research in your organization or community—these stories can be valuable in advocacy efforts and grant applications.
5. Monitor NIH RFA and FOA Announcements: Watch for shifts in funding priorities, new solicitations, or changes to review criteria as the budget process advances.

Outlook

The coming months will be pivotal. Congress must finalize appropriations before the fiscal year deadline. Watch for hearings, committee markups, and public statements from appropriators—especially in response to Parkinson's advocates’ push for increased disease-specific funding. Whether or not the $600 million target is achieved, advocacy pressure could shape final NIH allocations for all biomedical fields.

At Granted AI, we help grant seekers navigate shifting funding landscapes and tailor successful proposals—no matter what Congress decides next.